The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sejima, T.
Right arrow Articles by Sakata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sejima, T.
Right arrow Articles by Sakata, Y.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2005, 174: 8135-8143.
Copyright © 2005 by The American Association of Immunologists

Protection of Plasminogen Activator Inhibitor-1-Deficient Mice from Nasal Allergy1

Takayuki Sejima*,{dagger}, Seiji Madoiwa{dagger}, Jun Mimuro{dagger}, Teruko Sugo{dagger}, Kiyotaka Okada§, Shigeru Ueshima§, Osamu Matsuo§, Takashi Ishida{ddagger}, Keiichi Ichimura* and Yoichi Sakata2,{dagger}

* Department of Otorhinolaryngology-Head and Neck Surgery, and {dagger} Division of Cell and Molecular Medicine, Center for Molecular Medicine, Jichi Medical School, and {ddagger} Department of Otorhinolaryngology, International University of Health and Welfare Hospital, Tochigi, Japan; and § Department of Physiology II, Kinki University School of Medicine, Osakasayama City, Osaka, Japan

This study was performed to clarify the relationship between fibrinolytic components and the pathology of allergy, particularly that during the development of nasal allergy and nasal tissue changes. Intranasal OVA challenge after sensitization by i.p. administration of OVA induced a higher level of excess subepithelial collagen deposition in wild-type (WT) C57BL/6J mice than in plasminogen activator inhibitor (PAI)-1-deficient (PAI-1–/–) mice. The excess PAI-1 induction in the nasal mucosa and higher level of active PAI-1 in the nasal lavage fluid of WT-OVA mice compared with those in WT-control mice suggested that the decrease of proteolytic activity inhibits the removal of subepithelial collagen. The frequency of sneezing, nasal rubbing, nasal hyperresponsiveness, production of specific IgG1 and IgE in the serum, and production of IL-4 and IL-5 in splenocyte culture supernatant increased significantly in WT-OVA mice. In PAI-1–/– mice, these reactions were absent, and specific IgG2a in serum and IFN-{gamma} in splenocyte culture medium increased significantly. Histopathologically, there were marked goblet cell hyperplasia and eosinophil infiltration into the nasal mucosa in WT-OVA mice, but these were absent in PAI-1–/– mice. These results indicate that the immune response in WT-OVA mice can be classified as a dominant Th2 response, which would promote collagen deposition. In contrast, the Th2 response in PAI-1–/– mice was down-regulated, and the immune response shifted from Th2-dominant reaction to a Th1-dominant one. Taken together, these findings suggest that PAI-1 plays an important role not only in thrombolysis but also in immune response.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Kuramoto, T. Nishiuma, K. Kobayashi, M. Yamamoto, Y. Kono, Y. Funada, Y. Kotani, T. H. Sisson, R. H. Simon, and Y. Nishimura
Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L337 - L346.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Renckens, J. M. Pater, and T. v. d. Poll
Plasminogen Activator Inhibitor Type-1-Deficient Mice Have an Enhanced IFN-{gamma} Response to Lipopolysaccharide and Staphylococcal Enterotoxin B
J. Immunol., December 1, 2006; 177(11): 8171 - 8176.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.